<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Paris_Saclay_Notebook_September_23 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Paris Saclay/Notebook/September/23</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container-fluid nav-container"><NAV class="navbar navbar-default navbar-inverse affix-top" data-spy="affix" data-offset-top="260"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav center-block"><LI><A href="https://2016.igem.org/Team:Paris_Saclay">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Team">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Media">Media</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Sponsors">Sponsors</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Acknowledgements">Acknowledgements</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Background">Background</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Design">Design</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/CRISPR-Cas9">CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Strategy">Strategy</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Experiments">Experiments</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Notebook">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Description">Results</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Perspective">Perspective</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Interlab_Study">Interlab Study</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Basic_Part">Basic Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Pratices </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Silver">Societal Issues of CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Gold">Responsible Research and Innovation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices/GMO_Regulation">GMO regulation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Integrated_Practices">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Engagement">Engagement</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Model">Model</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Attributions">Attributions</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Safety">Safety</A></LI></DIV></DIV></NAV></DIV><DIV class="container content"><DIV id="main"><DIV id="toc" class="toc"><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Friday_23rd_September"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Friday 23<SUP>rd</SUP> September</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Visualization"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Visualization</SPAN></A></LI><LI class="toclevel-3 tocsection-3"><A href="#NanoDrop_Measurements"><SPAN class="tocnumber">1.1.1</SPAN><SPAN class="toctext">NanoDrop Measurements</SPAN></A></LI><LI class="toclevel-3 tocsection-4"><A href="#Gibson_of_cleaned_up_PCR_products_FKBP_from_8th_September_x_gblock_2.2_from_the_8th_September_x_pSB1C3_treated_by_DpnI_and_Gibson_of_PCR_product_containing_FKBP_-_GFP_10_from_the_22nd_September_x_pSB1C3_treated_by_DpnI"><SPAN class="tocnumber">1.1.2</SPAN><SPAN class="toctext">Gibson of cleaned up PCR products FKBP from 8th September x gblock 2.2 from the 8th September x pSB1C3 treated by DpnI and Gibson of PCR product containing FKBP - GFP 10 from the 22nd September x pSB1C3 treated by DpnI</SPAN></A></LI><LI class="toclevel-3 tocsection-5"><A href="#Transformation_of_DH5a_cells_with_FKBP_-_GFP_10_in_pSB1C3_.28pPS16_018.29_obtained_by_Gibson"><SPAN class="tocnumber">1.1.3</SPAN><SPAN class="toctext">Transformation of DH5a cells with FKBP - GFP 10 in pSB1C3 (pPS16_018) obtained by Gibson</SPAN></A></LI><LI class="toclevel-3 tocsection-6"><A href="#Glycerol_stocks_of_clones_2.2C_7_and_8_containing_corrected_dCas9_ST_-_GFP_11_in_pSB1C3_.28pPS16_017.29"><SPAN class="tocnumber">1.1.4</SPAN><SPAN class="toctext">Glycerol stocks of clones 2, 7 and 8 containing corrected dCas9 ST - GFP 11 in pSB1C3 (pPS16_017)</SPAN></A></LI><LI class="toclevel-3 tocsection-7"><A href="#Plasmids_extraction_of_clones_2.2C_7_and_8_containing_corrected_dCas9_ST_-_GFP_11_in_pSB1C3_.28pPS16_017.29"><SPAN class="tocnumber">1.1.5</SPAN><SPAN class="toctext">Plasmids extraction of clones 2, 7 and 8 containing corrected dCas9 ST - GFP 11 in pSB1C3 (pPS16_017)</SPAN></A></LI><LI class="toclevel-3 tocsection-8"><A href="#Glycerol_stocks_of_clones_3.2C_4.2C_7_and_8_containing_GFP_1.9_in_pSB1C3_.28pPS16_020.29"><SPAN class="tocnumber">1.1.6</SPAN><SPAN class="toctext">Glycerol stocks of clones 3, 4, 7 and 8 containing GFP 1.9 in pSB1C3 (pPS16_020)</SPAN></A></LI><LI class="toclevel-3 tocsection-9"><A href="#Plasmids_extraction_of_clones_3.2C_4.2C_7_and_8_containing_GFP_1.9_in_pSB1C3_.28pPS16_020.29"><SPAN class="tocnumber">1.1.7</SPAN><SPAN class="toctext">Plasmids extraction of clones 3, 4, 7 and 8 containing GFP 1.9 in pSB1C3 (pPS16_020)</SPAN></A></LI></UL></DIV><H1><SPAN class="mw-headline" id="Friday_23rd_September">Friday 23<SUP>rd</SUP> September</SPAN></H1><H3><SPAN class="mw-headline" id="Visualization">Visualization</SPAN></H3><H4><SPAN class="mw-headline" id="NanoDrop_Measurements">NanoDrop Measurements</SPAN></H4><P><I>By Maxence, Manhaz &amp; Coline</I></P><TABLE class="wikitable"><TBODY><TR><TH>Sample
</TH><TH>Concentration (ng/µL)
</TH></TR><TR><TD>FKBP amplification product from the 8th September</TD><TD>231.55
</TD></TR><TR><TD>gblock 2.2 amplification product from the 8th September</TD><TD>183.9
</TD></TR><TR><TD>pSB1C3 treated by DpnI from the 15th September</TD><TD>59.68
</TD></TR><TR><TD>PCR product containing FKBP - GFP 10 from the 22nd September</TD><TD>38.19
</TD></TR></TBODY></TABLE><P>As gblock 2.2 and FKBP were too concentrated, they were diluated at 1/10.
</P><H4><SPAN class="mw-headline" id="Gibson_of_cleaned_up_PCR_products_FKBP_from_8th_September_x_gblock_2.2_from_the_8th_September_x_pSB1C3_treated_by_DpnI_and_Gibson_of_PCR_product_containing_FKBP_-_GFP_10_from_the_22nd_September_x_pSB1C3_treated_by_DpnI">Gibson of cleaned up PCR products FKBP from 8th September x gblock 2.2 from the 8th September x pSB1C3 treated by DpnI and Gibson of PCR product containing FKBP - GFP 10 from the 22nd September x pSB1C3 treated by DpnI</SPAN></H4><P><I>By Maxence, Manhaz &amp; Coline</I></P><P>Gibson was performed with cleaned up PCR products FKBP (insert 1) (obtained the 8th September) x gblock 2.2 (insert 2) (obtained the 8th September) x pSB1C3 treated by DpnI (plasmid) with the following protocol:
</P><P>For each 20μl of reaction, mix the following reagents :
</P><UL><LI> 1.74 µL of insert 1</LI><LI> 1.78 µL of insert 2</LI><LI> 1.67 µL of plasmid</LI><LI> 4.81 µL of water</LI><LI> 10 µL of buffer mix</LI></UL><P>Furthermore, Gibson was performed with cleaned up PCR containing FKBP - GFP 10 (insert) x pSB1C3 treated by DpnI (plasmid) with the following protocol:
</P><P>For each 20μl of reaction, mix the following reagents :
</P><UL><LI> 1.89 µL of insert</LI><LI> 1.67 µL of plasmid</LI><LI> 6.44 µL of water</LI><LI> 10 µL of buffer mix</LI></UL><P>Two controls were done: one without insert and one without buffer (water was added in order to have a total of 20 µL). The PCR was performed as follow : 1 hour at 50°C.
</P><H4><SPAN class="mw-headline" id="Transformation_of_DH5a_cells_with_FKBP_-_GFP_10_in_pSB1C3_.28pPS16_018.29_obtained_by_Gibson">Transformation of DH5a cells with FKBP - GFP 10 in pSB1C3 (pPS16_018) obtained by Gibson</SPAN></H4><P><I>By Maxence &amp; Mahnaz</I></P><P>Dh5a cells were transformed with pSB1C3 containing FKBP - GFP 10 (pPS16_018), or controls (no buffer mix and plasmid alone) using the usual <A href="/Team:Paris_Saclay/Experiments#heat-shocktransformation" title="Team:Paris Saclay/Experiments">protocol</A>.
</P><H4><SPAN class="mw-headline" id="Glycerol_stocks_of_clones_2.2C_7_and_8_containing_corrected_dCas9_ST_-_GFP_11_in_pSB1C3_.28pPS16_017.29">Glycerol stocks of clones 2, 7 and 8 containing corrected dCas9 ST - GFP 11 in pSB1C3 (pPS16_017)</SPAN></H4><P><I>By Maxence, Mahnaz &amp; Coline</I></P><P>The glycerol stock of the bacteria with the following plasmids were made.
</P><UL><LI>pPS16_017 (dCas9 ST - GFP 11) clone 2</LI><LI>pPS16_017 (dCas9 ST - GFP 11) clone 7</LI><LI>pPS16_017 (dCas9 ST - GFP 11) clone 8</LI></UL><P>500µL of liquid culture and 250 µL of glycerol 60% were mixed and put at -20°C.
</P><H4><SPAN class="mw-headline" id="Plasmids_extraction_of_clones_2.2C_7_and_8_containing_corrected_dCas9_ST_-_GFP_11_in_pSB1C3_.28pPS16_017.29">Plasmids extraction of clones 2, 7 and 8 containing corrected dCas9 ST - GFP 11 in pSB1C3 (pPS16_017)</SPAN></H4><P><I>By Maxence, Mahnaz &amp; Coline</I></P><P>The following plasmids were extracted using the <A href="/Team:Paris_Saclay/Experiments#InvitrogenPlasmidExtraction" title="Team:Paris Saclay/Experiments">&quot;Charge Switch-Pro Plasmid Miniprep&quot;</A> kit:
</P><UL><LI>pPS16_017 (dCas9 ST - GFP 11) clone 2</LI><LI>pPS16_017 (dCas9 ST - GFP 11) clone 7</LI><LI>pPS16_017 (dCas9 ST - GFP 11) clone 8</LI></UL><H4><SPAN class="mw-headline" id="Glycerol_stocks_of_clones_3.2C_4.2C_7_and_8_containing_GFP_1.9_in_pSB1C3_.28pPS16_020.29">Glycerol stocks of clones 3, 4, 7 and 8 containing GFP 1.9 in pSB1C3 (pPS16_020)</SPAN></H4><P><I>By Maxence, Mahnaz &amp; Coline</I></P><P>The glycerol stock of the bacteria with the following plasmids were made.
</P><UL><LI>pPS16_020 (GFP 1.9) clone 3</LI><LI>pPS16_020 (GFP 1.9) clone 4</LI><LI>pPS16_020 (GFP 1.9) clone 7</LI><LI>pPS16_020 (GFP 1.9) clone 8</LI></UL><P>500µL of liquid culture and 250 µL of glycerol 60% were mixed and put at -20°C.
</P><H4><SPAN class="mw-headline" id="Plasmids_extraction_of_clones_3.2C_4.2C_7_and_8_containing_GFP_1.9_in_pSB1C3_.28pPS16_020.29">Plasmids extraction of clones 3, 4, 7 and 8 containing GFP 1.9 in pSB1C3 (pPS16_020)</SPAN></H4><P><I>By Maxence, Mahnaz &amp; Coline</I></P><P>The following plasmids were extracted using the <A href="/Team:Paris_Saclay/Experiments#InvitrogenPlasmidExtraction" title="Team:Paris Saclay/Experiments">&quot;Charge Switch-Pro Plasmid Miniprep&quot;</A> kit:
</P><UL><LI>pPS16_020 (GFP 1.9) clone 3</LI><LI>pPS16_020 (GFP 1.9) clone 4</LI><LI>pPS16_020 (GFP 1.9) clone 7</LI><LI>pPS16_020 (GFP 1.9) clone 8</LI></UL></DIV></DIV><DIV class=" footer"><DIV class="container"><DIV class="adress"><ADRESS>Université Paris Sud
91405 Orsay, France</ADRESS></DIV><SMALL class="envers copyright">Copyright © 2016 iGEM Paris Saclay. <STRIKE>All rights reserved</STRIKE> All inspirations encouraged.*This wiki was conceived during long nights of work and a great coffee experience in the beautiful Orsay, France.</SMALL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>